Clinical Trials Archives - Global Pharma Times

énergie fitness, UK’s premium gym chain franchise brings a business opportunity for Indian Entrepreneurs in 2021

Beyond Batten Disease Foundation partners with Actelion on development of combination treatment

Global Pharma Times

7 March 2021, Sunday

BDR Pharma launches Nintenib (Nintedanib) to treat Idiopathic Pulmonary Fibrosis in India

Trade News Network

October 20, 2020October 20, 2020

BDR Pharmaceutical today announces the launch of 100mg and 150 mg Nintedanib under the brand name Nintenib for the treatment of Idiopathic Pulmonary Fibrosis (IPF)....

Fidelis Pharmaceuticals Launches New Ethiqa XR™ Long-Lasting Control of Post-Procedural Pain Relief for Laboratory Rats and Mice

Trade News Network

August 19, 2020

Fidelis Pharmaceuticals today announced the availability of new Ethiqa XR (buprenorphine extended-release injectable suspension) 1.3 mg/mL. Ethiqa XR is the only pharmaceutical grade extended-release buprenorphine specifically...

Dalmia Healthcare Starts Clinical Trial with its Ayurvedic Composition to Treat COVID-19

Trade News Network

June 4, 2020June 4, 2020

Dalmia Healthcare, the healthcare division of Dalmia Group led by renowned industrialist Sanjay Dalmia, starts clinical trial to evaluate the efficacy and safety of polyherbal combination "Astha-15" for treatment...

Oncoinvent Announces Dosing of First Patient with Radspherin® in Phase 1 Clinical Trial

Trade News Network

June 2, 2020June 2, 2020

Oncoinvent AS, a clinical stage radiopharmaceutical company developing novel radioisotope-based therapies to provide new therapeutic options for cancer patients, today announced that the first patient...

AstronauTx Announces an Alliance With Concept Life Sciences to Accelerate the Identification of Novel Therapies For Alzheimer’s Disease

Trade News Network

June 2, 2020June 2, 2020

The therapeutics biotech AstronauTx announces a partnership with Concept Life Sciences, Contract Research Organisation, to progress the identification of novel therapies for Alzheimer's disease. The...

Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies

Trade News Network

May 31, 2020June 2, 2020

Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced...

CROMSOURCE Announces Launch of COVID-19 Clinical Trial

Trade News Network

April 7, 2020June 4, 2020

CROMSOURCE, an international contract research organization (CRO) with its global headquarters in Verona, Italy, has announced that it has initiated its first COVID-19 trial on behalf of...

Breaking News

Samarpit Kanwatia to amaze his clients with a newly designed dry-fit t-shirt

Samarpit Kanwatia, founder of Sarv Mangal Ho launches exclusive multipurpose mask

FDA approves Roche’s Actemra/RoActemra treatment for rare lung disease

Amgen to acquire Five Prime Therapeutics for approximately $1.9bn

Novartis signs agreement to manufacture CureVac’s COVID-19 vaccine

UK government invests £5m in COVID-19 mRNA vaccine library

ravkoo™, Digital Pharmacy to Deploy medifriendRx Prescription…

Takeda agree $856m deal with Ovid to take over soticlestat development

énergie fitness, UK’s premium gym chain franchise brings a business opportunity for Indian Entrepreneurs in 2021

Beyond Batten Disease Foundation partners with Actelion on development of combination treatment

BDR Pharma launches Nintenib (Nintedanib) to treat Idiopathic Pulmonary Fibrosis in India

Fidelis Pharmaceuticals Launches New Ethiqa XR™ Long-Lasting Control of Post-Procedural Pain Relief for Laboratory Rats and Mice

Dalmia Healthcare Starts Clinical Trial with its Ayurvedic Composition to Treat COVID-19

Oncoinvent Announces Dosing of First Patient with Radspherin® in Phase 1 Clinical Trial

AstronauTx Announces an Alliance With Concept Life Sciences to Accelerate the Identification of Novel Therapies For Alzheimer’s Disease

Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies

CROMSOURCE Announces Launch of COVID-19 Clinical Trial